KINETIC SOLUBILITY OF MEBENDAZOLE NANOCRYSTAL
DOI:
https://doi.org/10.36465/jkbth.v18i1.299Abstract
References
Buckton G & Beezer A E., 1992, Int. J. Pharm , The relationship between particle size and solubility, 82, R7–R10.
Calabro M L. et al., 2005, J Pharm Biomed Anal, The rutin/beta-cyclodextrin interactions in fully aqueous solution: Spectroscopic studies and biological assays, 36:1019–1027.
Dulfer WJ. et al., 1995, Environ Sci Technol, Micellar solubility and micelle/water partitioning of polychlorinated biphenyls in solutions of sodium dodecyl sulphate, 29:985–992.
Dupont B., 2002, J Antimicrob Chemother Suppl, Overview of the lipid formulations of amphotericin B. S1:31–36.
Eskandari M. et al., 2011, Journal of Pharmaceutical and Biomedical Analysis,Microextraction of mebendazole across supported liquid membrane forced by pH gradient and electrical field, 1173–1179
Kanaze FI. et al., 2006, J Appl Polym Sci, Dissolution enhancement of flavonoids by solid dispersion in PVP and PEG matrixes: A comparative study, 102:460–471.
Kumar M.P. et al., 2008, Current Nanoscience Formulation of Nanosuspensions of Albendazole for Oral Administration, 4, 53-58
Lawrence M & Rees G., 2000, Adv Drug Deliv Rev, Microemulsion-based media as novel drug delivery systems, 45:89–121.
Mauludin R et al., 2009, Eur J of Pharm Sci, Kinetic solubility and dissolution velocity of rutin nanocrystals, 36 : 502-510
Müller R H & Akkar A., 2004. Drug nanocrystals of poorly soluble drugs. In: Nalwa, H.S. (Ed.), Encyclopedia of Nanoscience and Nanotechnology. American Scientific Publishers, 627– 638.
Kumar M.P. et al., 2008, Current Nanoscience Formulation of Nanosuspensions of Albendazole for Oral Administration, 4, 53-58
Nakano M., 2000, Adv Drug Deliv Rev, Places of emulsions in drug delivery, 45:1–4.